US Must Learn Lessons From Europe On Biosimilars

 
• By Dave Wallace

Structural changes based on European experiences with biosimilars are “urgently needed” in the US to foster a successful biosimilars market, according to a joint report by Medicines for Europe and the US Biosimilars Forum.

Flags
The US Is Urged To Draw On European Experiences With Biosimilars • Source: Shutterstock

More from Biosimilars

More from Products